» Articles » PMID: 33282360

Transcatheter Aortic Valve Resection: New Mechanical Devices

Overview
Journal J Thorac Dis
Specialty Pulmonary Medicine
Date 2020 Dec 7
PMID 33282360
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To improve periprocedural outcomes of transcatheter aortic valve implantation (TAVI), transcatheter mechanical resection devices were tested for prior ablation of the aortic cusps.

Methods: Three mechanical transcatheter resection devices were tested in a series of native porcine (n=30) and reassembled calcified human valves (n=54). The resection time, the resected valve area, the number of released cusps, and the degree of surrounding tissue damage were measured. Afterwards, postmortem transapical-transcatheter-resections of the aortic valve in two humans were performed.

Results: In the native porcine hearts, the Aesculap II device demonstrated significantly shorter resection time compared to the R&R II and the Randstad devices (6.5±2.0 28.6±24.1 23.3±14.4 sec; P=0.001). However, it created more lesions in the surrounding tissue (P=0.002). The R&R II achieved a smaller number of resected cusps than the other two devices (2.7±0.7 1.1±0.7 2.4±0.5; P<0.001, respectively). It also resected a smaller area of the aortic valve (306.5±149.2 106.7±29.6 256.8±81.3 mm2; P=0.09) but a larger mean area of the resected fragments (110.3±41.5 160.7±29.6 111.5±43.9 mm2; P=0.01). The resection of the reassembled human valves demonstrated the same results between the devices regarding resection time (P=0.001) and resected area (P=0.016), but not fragment sizes (P=0.610). Finally, transapical-transcatheter-resection of aortic valve was performed in two cadavers.

Conclusions: Transcatheter aortic valve resection is feasible with variable aortic leaflet resection times and mild risk of lesions of the surrounding tissue.

References
1.
Rohde I, Masch J, Theisen-Kunde D, Marczynski-Buhlow M, Bombien Quaden R, Lutter G . Resection of calcified aortic heart leaflets in vitro by Q-switched 2 µm microsecond laser radiation. J Card Surg. 2014; 30(2):157-62. DOI: 10.1111/jocs.12481. View

2.
Leber A, Kasel M, Ischinger T, Ebersberger U, Antoni D, Schmidt M . Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system. Int J Cardiol. 2011; 166(3):652-7. DOI: 10.1016/j.ijcard.2011.11.091. View

3.
Lutter G, Ardehali R, Cremer J, Bonhoeffer P . Percutaneous valve replacement: current state and future prospects. Ann Thorac Surg. 2004; 78(6):2199-206. DOI: 10.1016/j.athoracsur.2004.09.019. View

4.
Marczynski-Buhlow M, Gro J, Berndt R, Rocken C, Wedel T, Bottner M . Comparison of different resection tools for human calcified aortic valves. Innovations (Phila). 2014; 9(4):312-6. DOI: 10.1097/IMI.0000000000000085. View

5.
Wendt D, Muller W, Hauck F, Thielmann M, Wendt H, Kipfmuller B . In vitro results of a new minimally invasive aortic valve resecting tool. Eur J Cardiothorac Surg. 2009; 35(4):622-7. DOI: 10.1016/j.ejcts.2009.01.005. View